Concepedia

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

Francisco Javier Carretero, Ana Belén Campo, José Francisco Flores-Martín, Rosa Méndez, César García-López, José Manuel Cózar, Victoria Adams, Stephen Ward, Teresa Cabrera, Francisco Ruiz‐Cabello,

Cancer Immunology Immunotherapy · 2015 · 50 citations · 33 references

DOIFull text

Open access

Concepts

References

33

Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer

Anthony V. D’Amico · JAMA · 1998 · 4.5K citations

Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer

Martin G. Sanda, Nicholas P. Restifo, Jessica C. Walsh et al. · JNCI Journal of the National Cancer Institute · 1995 · 238 citations · Full text

Loss of HLA class I expression in prostate cancer: Implications for immunotherapy

Rosemary A. Blades, Patrick Keating, L J McWilliam et al. · Urology · 1995 · 194 citations

, , +9

HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.

Marco Vitale, Rita Rezzani, Luigi Fabrizio Rodella et al. · PubMed · 1998 · 171 citations

, , +14

Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma

Ana Belén Campo, Jon Amund Kyte, Javier Carretero et al. · International Journal of Cancer · 2013 · 140 citations · Full text

, , +16